Actively Recruiting

Phase 1
Age: 18Years - 49Years
All Genders
Healthy Volunteers
NCT07168915

A Study of V118E in Healthy Participants (V118E-003)

Led by Merck Sharp & Dohme LLC · Updated on 2026-02-27

126

Participants Needed

4

Research Sites

109 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are looking for new vaccines to prevent illnesses caused by a type of bacteria called Streptococcus pneumoniae. There are many different types of Streptococcus pneumoniae bacteria, called serotypes. Vaccines contain small parts of certain serotypes. These parts will not cause an infection but help the body create antibodies (proteins) to fight the bacteria. PREVNAR 20™ is a vaccine given to help to prevent disease from Streptococcus pneumoniae bacteria. Researchers designed a new vaccine, V118E, to help prevent disease from Streptococcus pneumoniae bacteria. The goal of this study is to learn how safe V118 formulation E is in Healthy Adults and how well people tolerate it.

CONDITIONS

Official Title

A Study of V118E in Healthy Participants (V118E-003)

Who Can Participate

Age: 18Years - 49Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Be in good health before randomization
Not Eligible

You will not qualify if you...

  • Have had invasive pneumococcal disease or other culture-positive pneumococcal disease within 3 years before vaccination
  • Have a history of significant endocrine, gastrointestinal, cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological diseases including stroke and chronic seizures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Velocity Clinical Research, Hallandale Beach ( Site 0003)

Hallandale, Florida, United States, 33009

Actively Recruiting

2

QPS-MRA, LLC-Early Phase ( Site 0002)

South Miami, Florida, United States, 33143

Actively Recruiting

3

Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0004)

Springfield, Missouri, United States, 65802

Actively Recruiting

4

University of Texas Medical Branch ( Site 0001)

Galveston, Texas, United States, 77555-1115

Actively Recruiting

Loading map...

Research Team

T

Toll Free Number

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here